These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 13929634)

  • 21. RESPONSE TO ONE DOSE OF TRIVALENT ORAL POLIOVACCINE IN CHILDREN PREVIOUSLY IMMUNISED WITH SALK VACCINE: A COMPARISON OF LIQUID VACCINE AND A CAPSULE PRESENTATION.
    BEALE AJ; DAVIES JR; THROWER AL
    Lancet; 1965 Apr; 1(7391):879-81. PubMed ID: 14272682
    [No Abstract]   [Full Text] [Related]  

  • 22. THE POLIOMYELITIS IMMUNIZATION PROGRAMME IN SINGAPORE.
    LEE LH; LIM KA; KANAGARATNAM K
    Singapore Med J; 1965 Jun; 5():89-95. PubMed ID: 14341533
    [No Abstract]   [Full Text] [Related]  

  • 23. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. II. STUDIES ON TYPE 3 STRAINS.
    FURESZ J; ARMSTRONG RE; MOREAU P; NAGLER FP
    Am J Hyg; 1964 Jul; 80():55-61. PubMed ID: 14192770
    [No Abstract]   [Full Text] [Related]  

  • 24. NEUTRALIZING ANTIBODIES IN FAECAL EXTRACTS DURING POLIOMYELITIS LIVE VACCINE IMMUNIZATION.
    MASSON AM; ROGALA E; ROLLAND D
    Can J Public Health; 1965 Jul; 56():276-80. PubMed ID: 14343213
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anti-poliomyelitis vaccination campaign and comparative evaluation of the vaccines].
    MATILLA V
    Med Trop (Madr); 1963; 39():127-49. PubMed ID: 13933670
    [No Abstract]   [Full Text] [Related]  

  • 26. [ORAL IMMUNIZATION OF NEWBORN INFANTS WITH TYPE I SABIN LIVE POLIOMYELITIS VACCINE].
    BELIAN WA; BOETHIG B; BUELL H; HEMPEL HC
    Dtsch Gesundheitsw; 1964 Apr; 19():723-31. PubMed ID: 14216233
    [No Abstract]   [Full Text] [Related]  

  • 27. [THE VALUE OF GENETIC MARKERS OF THE POLIOVIRUS FOR THE EVALUATION OF SUPPOSED INCIDENTS FOLLOWING ORAL VACCINATION].
    POETSCH F
    Zentralbl Bakteriol Orig; 1963 Dec; 191():112-6. PubMed ID: 14119890
    [No Abstract]   [Full Text] [Related]  

  • 28. Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan.
    Shimizu H
    Vaccine; 2016 Apr; 34(16):1975-85. PubMed ID: 25448090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ON A CASE OF ACUTE HEMORRHAGIC GLOMERULONEPHRITIS IN THE COURSE OF SABIN TYPE POLIO VACCINATION].
    GAMALERO PC; CANESTRI G
    G Mal Infett Parassit; 1965 May; 17():293-4. PubMed ID: 14341362
    [No Abstract]   [Full Text] [Related]  

  • 30. ORAL POLIOMYELITIS VACCINATION PROGRAM IN BERKS COUNTY, PENNSYLVANIA.
    HAYMAN CR; BOCK HB; TURNBULL C; PETTIS GS
    Public Health Rep (1896); 1965 May; 80(5):417-22. PubMed ID: 14290591
    [No Abstract]   [Full Text] [Related]  

  • 31. [Contribution to the problem of complications following peroral poliomyelitis vaccination].
    FISCHER HR; SCHAER M; PULVER W
    Ther Umsch; 1963 Mar; 20():124-8. PubMed ID: 13963019
    [No Abstract]   [Full Text] [Related]  

  • 32. [Anti-poliomyelitis vaccination with attenuated live virus].
    BONNET F; LAMBRECHTS A
    Rev Med Liege; 1963 Mar; 18():140-8. PubMed ID: 13968824
    [No Abstract]   [Full Text] [Related]  

  • 33. [SHOULD ATTENUATED POLIOMYELITIS VIRUS VACCINE BE ADMINISTERED TO SUBJECTS PREVIOUSLY VACCINATED BY KILLED VIRUS?].
    GILLET P; THIRY L
    Acta Paediatr Belg; 1964; 18():145-61. PubMed ID: 14166431
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anti-poliomyelitis vaccinations. Live vaccines and inactivated vaccines. Respective indications. Current status of the problem].
    CROSNIER
    Rev Pathol Gen Physiol Clin; 1962 May; 62():467-92. PubMed ID: 14041410
    [No Abstract]   [Full Text] [Related]  

  • 35. [REACTIONS AND COMPLICATIONS FOLLOWING ORAL POLIOMYELITIS VACCINATION. I].
    JOPPICH G; KOLLER S
    Dtsch Med Wochenschr; 1965 Jul; 90():1197-200. PubMed ID: 14303427
    [No Abstract]   [Full Text] [Related]  

  • 36. CURRENT IMMUNIZATION METHODS AND PRECAUTIONS.
    WEHRLE PF
    Calif Med; 1964 Sep; 101(3):153-9. PubMed ID: 14199083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current status of oral anti-poliomyelitis vaccination with attenuated live virus].
    BACIGALUPI JC
    Arch Pediatr Urug; 1963 Feb; 34():100-11 contd. PubMed ID: 13965933
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current status of oral anti-poliomyelitis vaccination with attenuated live virus].
    BACIGALUPI JC
    Arch Pediatr Urug; 1963 Mar; 34():175-84. PubMed ID: 13965932
    [No Abstract]   [Full Text] [Related]  

  • 39. [Killed (Salk type) or living (Sabin type) poliomyelitis vaccine?].
    VERLINDE JD
    Ned Tijdschr Geneeskd; 1962 Dec; 106():2599-604. PubMed ID: 13996794
    [No Abstract]   [Full Text] [Related]  

  • 40. [REACTIONS AND COMPLICATIONS FOLLOWING ORAL POLIOMYELITIS VACCINATION. II].
    PETTE H
    Dtsch Med Wochenschr; 1965 Jul; 90():1200-3. PubMed ID: 14303428
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.